StockWatch
·

BAL PHARMA LTD. Q2 FY26 Results

BALPHARMAQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue74.0212.4%0.5%
Total Income75.1412.8%2.3%
Expenditure74.4212.1%3.2%
PBT0.72244.0%47.3%
Net Profit0.72244.0%31.1%
OPM7.74%1.46pp13.94pp
NPM0.95%0.64pp0.47pp
EPS0.45246.2%30.8%
View full financials

Informational and educational content only. Not investment advice.